Atomoxetine Hydrochloride
NDC 60505-2835, atomoxetine hydrochloride, capsule, from Apotex Corp..
- Product NDC
- 60505-2835
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078983
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-2835 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOMOXETINE HYDROCHLORIDE80 mg/1
Pharmacologic classes
Norepinephrine Reuptake Inhibitor [EPC]; Norepinephrine Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-2835-3 | 60505283503 | 30 CAPSULE in 1 BOTTLE (60505-2835-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/132852a6-5bff-15dd-255c-98309dd83630NADAC price for package 60505283503
GET /v1/drugs/nadac/60505283503
Use it
Look up 60505-2835 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-2835 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-2835. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.